NEW YORK (GenomeWeb News) – Hologic today said that its $3.7 billion deal to acquire Gen-Probe has cleared US antitrust review.

The Bedford, Mass.-based firm said that the initial 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 had expired without a request for additional information from the US Federal Trade Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.